Trials / Sponsors / Gipfel Life Sciences GmbH
Gipfel Life Sciences GmbH
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inh ALS (Amyotrophic Lateral Sclerosis) | Phase 2 / Phase 3 | 2026-06-30 |